Local ablative treatments for hepatocellular carcinoma: An updated review

Ablative treatments currently represent the first-line option for the treatment of early stage unresectable hepatocellular carcinoma (HCC). Furthermore, they are effective as bridging/downstaging therapies before orthotopic liver transplantation. Contraindications based on size, number, and location...

Descripción completa

Detalles Bibliográficos
Autores principales: Facciorusso, Antonio, Serviddio, Gaetano, Muscatiello, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095567/
https://www.ncbi.nlm.nih.gov/pubmed/27867681
http://dx.doi.org/10.4292/wjgpt.v7.i4.477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095567/
https://www.ncbi.nlm.nih.gov/pubmed/27867681
http://dx.doi.org/10.4292/wjgpt.v7.i4.477

Ejemplares similares